atranorin has been researched along with Inflammation in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Atanasov, AG; Kamal, MA; Khan, H; Nabavi, SM; Pervaiz, A; Rengasamy, KRR | 1 |
| Feng, CL; Huang, GG; Lei, SY; Lin, X; Ren, J; Tang, W; Wang, HY; Wu, YW; Zhang, KR; Zhou, R | 1 |
1 review(s) available for atranorin and Inflammation
| Article | Year |
|---|---|
Plant-derived mPGES-1 inhibitors or suppressors: A new emerging trend in the search for small molecules to combat inflammation.
Topics: Animals; Anti-Inflammatory Agents; Biological Products; Drug Discovery; Enzyme Inhibitors; Humans; Inflammation; Plants, Medicinal; Prostaglandin-E Synthases | 2018 |
1 other study(ies) available for atranorin and Inflammation
| Article | Year |
|---|---|
Atranorin inhibits NLRP3 inflammasome activation by targeting ASC and protects NLRP3 inflammasome-driven diseases.
Topics: Animals; Arthritis, Gouty; Colitis, Ulcerative; Inflammasomes; Inflammation; Interleukin-1beta; Mice; Mice, Inbred C57BL; NLR Family, Pyrin Domain-Containing 3 Protein | 2023 |